Upregulation of osteoclast activity in the development of RA is controlled by osteocytes through the osteoprotegerin/RANKL/RANK (OPG/RANKL/RANK) system (Zhang and Wen, 2021). This evidence concerns the gene TNFRSF11B and rheumatoid arthritis.